-
4
-
-
0036925632
-
Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder
-
Barkley, R.A. (2002). Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 63(Suppl. 12), 10-15.
-
(2002)
Journal of Clinical Psychiatry
, vol.63
, Issue.SUPPL. 12
, pp. 10-15
-
-
Barkley, R.A.1
-
5
-
-
0025324595
-
The adolescent outcome of hyperactive children diagnosed by research criteria. Part 1: An 8-year prospective follow-up study
-
Barkley, R.A., Fischer, M., Edelbrock, C.S., & Smallish, L. (1990). The adolescent outcome of hyperactive children diagnosed by research criteria. Part 1: An 8-year prospective follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 546-557.
-
(1990)
Journal of the American Academy of Child and Adolescent Psychiatry
, vol.29
, pp. 546-557
-
-
Barkley, R.A.1
Fischer, M.2
Edelbrock, C.S.3
Smallish, L.4
-
6
-
-
0036638788
-
Driving in young adults with attention deficit hyperactivity disorder: Knowledge, performance, adverse outcomes and the role of executive functions
-
Barkley, R.A., Murphy, K.R., DuPaul, G.I., & Bush, T. (2002). Driving in young adults with attention deficit hyperactivity disorder: Knowledge, performance, adverse outcomes and the role of executive functions. Journal of International Neuropsychology Society, 8, 655-672.
-
(2002)
Journal of International Neuropsychology Society
, vol.8
, pp. 655-672
-
-
Barkley, R.A.1
Murphy, K.R.2
DuPaul, G.I.3
Bush, T.4
-
7
-
-
0024804130
-
-
Biederman, J., Baldessarini, R.J., Wright, V., Knee, D., Harmatz, J.S., & Goldblatt, A. (1989). A double-blind placebo controlled study of desipramine in the treatment ADD, II: Serum drug levels and cardiovascular findings. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 903-911.
-
Biederman, J., Baldessarini, R.J., Wright, V., Knee, D., Harmatz, J.S., & Goldblatt, A. (1989). A double-blind placebo controlled study of desipramine in the treatment ADD, II: Serum drug levels and cardiovascular findings. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 903-911.
-
-
-
-
8
-
-
0000925786
-
Anterior cingulated cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop
-
Bush, G., Frazier, J.A., Rauch, S.L., Seidmann, L.J., Whalen, P.J. Jenike, M.A., et al. (1999). Anterior cingulated cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biological Psychiatry, 45, 1542-1552.
-
(1999)
Biological Psychiatry
, vol.45
, pp. 1542-1552
-
-
Bush, G.1
Frazier, J.A.2
Rauch, S.L.3
Seidmann, L.J.4
Whalen, P.J.5
Jenike, M.A.6
-
9
-
-
0036848458
-
Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention-deficit/hyperactivity disorder
-
Bymaster, F.P., Katner, J.S., Nelson, D.L., Hemrick-Lueke, S.K., Threlkeld, P.G., Heiligenstein, J.H., et al. (2002). Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention-deficit/hyperactivity disorder. Neuropsychopharmacology, 27, 699-711.
-
(2002)
Neuropsychopharmacology
, vol.27
, pp. 699-711
-
-
Bymaster, F.P.1
Katner, J.S.2
Nelson, D.L.3
Hemrick-Lueke, S.K.4
Threlkeld, P.G.5
Heiligenstein, J.H.6
-
11
-
-
0029819433
-
Bupropion hydrochloride in attention deficit disorder with hyperactivity
-
Conners, C.K., Casat, C.D., Gualtieri, C.T., Weller, E., Reader, M., & Reiss, A., et al. (1996). Bupropion hydrochloride in attention deficit disorder with hyperactivity. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1314-1321.
-
(1996)
Journal of the American Academy of Child and Adolescent Psychiatry
, vol.35
, pp. 1314-1321
-
-
Conners, C.K.1
Casat, C.D.2
Gualtieri, C.T.3
Weller, E.4
Reader, M.5
Reiss, A.6
-
12
-
-
0033982174
-
A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder
-
Connor, D.F., Barkley, R.A., & Davis, H.T. (2000). A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clinical Pediatrics, 39, 15-25.
-
(2000)
Clinical Pediatrics
, vol.39
, pp. 15-25
-
-
Connor, D.F.1
Barkley, R.A.2
Davis, H.T.3
-
13
-
-
53849147672
-
-
and Company, Retrieved July 1, 2003, from
-
Eli Lilly and Company. (2003). Strattera. Retrieved July 1, 2003, from http://pi.lilly.com/us/strattera-pi.pdf
-
(2003)
Strattera
-
-
Lilly, E.1
-
14
-
-
0032146143
-
DOPA decarboxylase activity in attention deficit hyperactivity disorder adults: A [fluorine-18]fluorodopa positron emission tomographic study
-
Ernst, M., Zametkin, A.J., Matochik, P.H., Jons, P.H., & Cohen, R.M. (1998). DOPA decarboxylase activity in attention deficit hyperactivity disorder adults: A [fluorine-18]fluorodopa positron emission tomographic study. Journal of Neuroscience, 18, 5901-5907.
-
(1998)
Journal of Neuroscience
, vol.18
, pp. 5901-5907
-
-
Ernst, M.1
Zametkin, A.J.2
Matochik, P.H.3
Jons, P.H.4
Cohen, R.M.5
-
16
-
-
0036633805
-
Atomoxetine and methylphenidate treatment in children with ADHD: A prospective randomized, open-label trial
-
Kratochvil, C.J., Heiligenstein, J.H., Dittman, R., Spencer, T.J., Biederman, J., Wernicke, J., et al. (2002). Atomoxetine and methylphenidate treatment in children with ADHD: A prospective randomized, open-label trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 776-784.
-
(2002)
Journal of the American Academy of Child and Adolescent Psychiatry
, vol.41
, pp. 776-784
-
-
Kratochvil, C.J.1
Heiligenstein, J.H.2
Dittman, R.3
Spencer, T.J.4
Biederman, J.5
Wernicke, J.6
-
17
-
-
0012273661
-
-
Retrieved June 23, 2003, from
-
Lesesne, C., Abramowitz, A., Perou, R., & Brann, E. (2000). Attention deficit/hyperactivity disorder: A public health research agenda. Retrieved June 23, 2003, from http://www.cdc.gov/ncbddd/adhd/ dadphra.htm.
-
(2000)
Attention deficit/hyperactivity disorder: A public health research agenda
-
-
Lesesne, C.1
Abramowitz, A.2
Perou, R.3
Brann, E.4
-
18
-
-
0012101373
-
-
Retrieved June 23, 2003, from
-
National Center for Educational Statistics (2001). Dropout rates in the United States: 2000. Retrieved June 23, 2003, from http://nces.ed.gov/ pubs2002/2002114.pdf.
-
(2001)
Dropout rates in the United States: 2000
-
-
-
19
-
-
53849122056
-
Diagnosis and treatment of attention deficit hyperactivity disorder in youth and adults
-
R.I. Shader Ed, Philadelphia: Lippincott Williams and Wilkins
-
Oesterheld, J.R., Shader, R.I., & Wender, P.H. (2003). Diagnosis and treatment of attention deficit hyperactivity disorder in youth and adults. In R.I. Shader (Ed.), Manual of psychiatric therapeutics (pp. 346-364). Philadelphia: Lippincott Williams and Wilkins.
-
(2003)
Manual of psychiatric therapeutics
, pp. 346-364
-
-
Oesterheld, J.R.1
Shader, R.I.2
Wender, P.H.3
-
20
-
-
0031459908
-
Antidepressants for ADHD
-
Popper, C.W. (1992). Antidepressants for ADHD. Journal of Clinical Psychiatry, 58, (Suppl. 14), 14-29.
-
(1992)
Journal of Clinical Psychiatry
, vol.58
, Issue.SUPPL. 14
, pp. 14-29
-
-
Popper, C.W.1
-
21
-
-
0030007830
-
Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: A systematic chart review of 62 cases
-
Prince, J.B., Wilens, T.E., Biederman, J., & Spencer, T.J. (1996). Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: A systematic chart review of 62 cases. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 599-605.
-
(1996)
Journal of the American Academy of Child and Adolescent Psychiatry
, vol.35
, pp. 599-605
-
-
Prince, J.B.1
Wilens, T.E.2
Biederman, J.3
Spencer, T.J.4
-
22
-
-
0016238048
-
Imipramine and methylphenidate treatments of hyperactive boys: A double-blind comparison
-
Rapoport, J.L., Quinn, P.O., Bradbard, G., Riddle, K.D., & Brooks, E. (1974). Imipramine and methylphenidate treatments of hyperactive boys: a double-blind comparison. Archives of General Psychiatry, 30, 789-793.
-
(1974)
Archives of General Psychiatry
, vol.30
, pp. 789-793
-
-
Rapoport, J.L.1
Quinn, P.O.2
Bradbard, G.3
Riddle, K.D.4
Brooks, E.5
-
23
-
-
0036925161
-
Adaptive changes related to medication treatment of ADHD: Listening to parents of children in clinical trials of a novel nonstimulant medication
-
Saylor, K.E., Buermeyer, C.M., Spencer, T.J., & Barkley, R.A. (2002). Adaptive changes related to medication treatment of ADHD: Listening to parents of children in clinical trials of a novel nonstimulant medication. Journal of Clinical Psychiatry, 63 (Suppl. 12), 23-28.
-
(2002)
Journal of Clinical Psychiatry
, vol.63
, Issue.SUPPL. 12
, pp. 23-28
-
-
Saylor, K.E.1
Buermeyer, C.M.2
Spencer, T.J.3
Barkley, R.A.4
-
24
-
-
0034940566
-
A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder
-
Scahill, L., Chappell, P.B., Kim, Y.S., Schultz, R.T., Katsovitch, L., Shepherd, E., et al. (2001). A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. American Journal of Psychiatry, 158, 1067-1074.
-
(2001)
American Journal of Psychiatry
, vol.158
, pp. 1067-1074
-
-
Scahill, L.1
Chappell, P.B.2
Kim, Y.S.3
Schultz, R.T.4
Katsovitch, L.5
Shepherd, E.6
-
25
-
-
0035687397
-
How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis
-
Schachter, H.M., Pham, B., King, J., Langford, S., & Moher, D. (2001). How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Canadian Medical Association Journal, 165, 1475-1488.
-
(2001)
Canadian Medical Association Journal
, vol.165
, pp. 1475-1488
-
-
Schachter, H.M.1
Pham, B.2
King, J.3
Langford, S.4
Moher, D.5
-
26
-
-
0038700760
-
Determining and achieving therapeutic targets in attention-deficit/hyperactivity disorder
-
Spencer, T. (2003). Determining and achieving therapeutic targets in attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 64, 265-276.
-
(2003)
Journal of Clinical Psychiatry
, vol.64
, pp. 265-276
-
-
Spencer, T.1
-
27
-
-
0034786182
-
An open-label, dose-ranging study of atomoxetine in children with attention-deficit/hyperactivity disorder
-
Spencer, T., Biederman, J., Heiligenstein, J., Wilens, T., Faries, D., Prince, J., et al. (2001). An open-label, dose-ranging study of atomoxetine in children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 11, 251-265.
-
(2001)
Journal of Child and Adolescent Psychopharmacology
, vol.11
, pp. 251-265
-
-
Spencer, T.1
Biederman, J.2
Heiligenstein, J.3
Wilens, T.4
Faries, D.5
Prince, J.6
-
28
-
-
0036920803
-
Novel treatments for attention-deficit/hyperactivity disorder in children
-
Spencer, T., Biederman, J., Wilens, T.E., & Faraone, S.V. (2002). Novel treatments for attention-deficit/hyperactivity disorder in children. Journal of Clinical Psychiatry, 63(Suppl. 12), 16-22.
-
(2002)
Journal of Clinical Psychiatry
, vol.63
, Issue.SUPPL. 12
, pp. 16-22
-
-
Spencer, T.1
Biederman, J.2
Wilens, T.E.3
Faraone, S.V.4
-
29
-
-
0036935774
-
Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/ hyperactivity disorder
-
Spencer, T., Heiligenstein, J.H., Biederman, J., Faries, D.E., Kratochvil, C.J., Conners, C.K., et al. (2002). Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/ hyperactivity disorder. Journal of Clinical Psychiatry, 63, 1140-1147.
-
(2002)
Journal of Clinical Psychiatry
, vol.63
, pp. 1140-1147
-
-
Spencer, T.1
Heiligenstein, J.H.2
Biederman, J.3
Faries, D.E.4
Kratochvil, C.J.5
Conners, C.K.6
-
30
-
-
0037362361
-
Mechanism of action of selective NRIs: Both dopamine and norepinephrine increase in prefrontal cortex
-
Stahl, S.M. (2003). Mechanism of action of selective NRIs: Both dopamine and norepinephrine increase in prefrontal cortex. Journal of Clinical Psychiatry, 64, 230-231.
-
(2003)
Journal of Clinical Psychiatry
, vol.64
, pp. 230-231
-
-
Stahl, S.M.1
-
31
-
-
0035100341
-
Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder
-
Taylor, F.B., & Russo, J. (2001). Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology, 21, 223-228.
-
(2001)
Journal of Clinical Psychopharmacology
, vol.21
, pp. 223-228
-
-
Taylor, F.B.1
Russo, J.2
-
32
-
-
0033038226
-
Genetic basis of attention deficit and hyperactivity
-
Thapar, A., Holmes, J., Poulton, K., & Harrington, R. (1999). Genetic basis of attention deficit and hyperactivity. British Journal of Psychiatry, 174, 105-111.
-
(1999)
British Journal of Psychiatry
, vol.174
, pp. 105-111
-
-
Thapar, A.1
Holmes, J.2
Poulton, K.3
Harrington, R.4
-
33
-
-
0034957997
-
Adults with ADHD: An overview
-
Wender, P.H., Wolf, L.E., & Wasserstein, J. (2001). Adults with ADHD: An overview. Annals of the New York Academy of Science, 931, 1-16.
-
(2001)
Annals of the New York Academy of Science
, vol.931
, pp. 1-16
-
-
Wender, P.H.1
Wolf, L.E.2
Wasserstein, J.3
-
34
-
-
0021967020
-
Treatment of hyperactive children with monoamine oxidase inhibitors, I: Clinical efficacy
-
Zametkin, A., Rapoport, J.L., Murphy, D.L., Linnoila, M., & Ismond, D. (1985). Treatment of hyperactive children with monoamine oxidase inhibitors, I: Clinical efficacy. Archives of General Psychiatry, 42, 962-966.
-
(1985)
Archives of General Psychiatry
, vol.42
, pp. 962-966
-
-
Zametkin, A.1
Rapoport, J.L.2
Murphy, D.L.3
Linnoila, M.4
Ismond, D.5
|